Having known people who ended up hospitalized because the nurse LIED and said she was given a vaccine with no gluten in it (probably in the form of MSG. MSG has been shown to cause brain damage in laboratory animals.) , I am dubious about the safety and efficacy of entire process, from creation to injection.
Based on federal recommendations an 18-month-old-child could receive 22 shots of 12 vaccine in 32 doses.
Read a few of the inserts from those injections and tell me this is acceptable.
http://www.vaccineawareness.org/concerns.htm"IVAC is concerned with the cross-species in the culture mediums, i.e., chicken embryos, guinea pig cells, monkey kidney cells. SV40, implicated in many cancers, was in the polio vaccines from 1955-1962"
Measles, Mumps and Rubella (German measles) Live virus VaccineM-M-R II, vaccine package insert summary, Merck & Co., Whitehouse Station, NJ October 2003
Ingredients-Attenuvax: live measles virus from Eders’ weakened Edmonston strain grown in chick embryo cell culture;
-Mumpsvax: Jerry Lynn (B level) strain of live mumps virus grown in chick embryo cell culture;
-Meruvax:Wistar RA 27/3 strain of live weakened rubella virus grown in WI-38 aborted human lung fibroblasts (connective tissue cells);
-fetal bovine serum;
-hydrolyzed gelatin;
-glutamate;
-human albumin (processed using Cohn cold ethanol fractionation,
-medium 199
-Minimum Essential Medium;
-neomycin;
-sodium chloride;
-sodium phosphate;
-sorbitol;
-sucrose;
Contraindications-hypersensitivity reaction to ingredients including gelatin;
-no vaccination for pregnant women; unknown vaccine effects on fetus;
-pregnancy avoided for 3 months after vaccination;
-respiratory fever; active fever infection
Warnings-elevated fever may occur after vaccination;
-remote risk of viral disease from albumin, derivative of human blood;
-theoretical risk of Creutzfeldt-Jacob disease (CJD);
-hypersensitivity to ingredients including eggs, neomycin;
-people with thrombocytopenis (low platelets resulting in bleeding and easy bruising);
Precautions-epinephrine available for possible allergic reaction;
-transmission of rubella virus through breast milk;
-unknown if measles or mumps virus excreted in breast milk;
-deferred vaccination (3 months or longer) after transfusions or human immune globulin;
-live rubella virus excretion from nose or throat of susceptible people 7-28 days after vaccination, transmission through close contact , accepted as theoretical risk, not regarded as a significant risk;
-reports of individual measles, mumps, rubella vaccines may result in temporary depression of tuberculin skin sensitivity;
-no studies on effect of measles vaccine on untreated tuberculosis children;
-no vaccination for people with active, untreated tuberculosis;
-no evaluation for carcinogenicity, mutagenicity or fertility impairment;
-no animal reproduction studies;
-unknown if vaccine can cause fetal harm when injected into a pregnant woman or can affect reproduction capacity;
-pregnancy avoided for 3 months after vaccination;
-safety and effectiveness to established for measles vaccine in infants under 6 months;
-safety ad effectiveness not established for mumps and rubella vaccine in infants less than 12 months;
-M-M-R II given one month before or after other live virus vaccines;
-limited data, thus not recommended, for simultaneous vaccination with diphtheria/pertussis/tetanus (DPT) and or oral polio vaccine (OPV);
Adverse Reactions: arthritis, atypical measles, brain disease, convulsions, cough, death (reported rarely, no established causal link), diabetes, diarrhea, dizziness, ear, (middle infection) and nerve deafness, edema, eye paralysis, fainting, fever, Guillain-Barre Syndrome, headache, injection site-burning, redness, stinging, swelling, tenderness, tissue hardening, irritability, itchiness, hives, meningitis (aseptic), sclerosis (brain), nausea, nerve inflammation, nose inflammation, pitting of abdomen & thigh, pneumonia, rash, seizures, sore throat, testes inflammation, upper respiratory infection, visual disturbances, vomiting, weakness. More adverse reactions are listed.
(Pneumoccal 7-valent vaccine, Diphtheria Protein)Prevnar, vaccine package insert summary, Wyeth Pharmaceuticals. Inc., Philadelphia, PA, January 2004
Ingredients:-Streptococcus pneumoniae stereotypes 4, 6B, 9V, 14, 18C, 19F, 23F
joined to diphtheria CRM protein isolated from cultures of Coynebacterium diphtheria strain C7 (B197);
-aluminum phosphate;
-ammonium sulfate
-casamioacids;
-soy peptone broth
-yeast;
Contraindications-hypersensitivity reaction to ingredients including diptherua weakened toxin;
-delay for severe or moderate fever;
Warnings-no protection from diseases caused by serotypes unrelated to those vaccine;
-package contains dry natural rubber;
-Sudden Infant Death Syndrome (SIDS) mentioned in specific studies;
Precautions-fever and seizure reported after vaccination;
-acetaminophen may be given to reduce possibility of post-vaccination fever;
-given with caution for children on anti-coagulant therapy;
-unknown clinical relevance for inconsistent differences in response to pertussis atingens;
-unavailable immune data for MMR and chickenpox vaccine with Prevnars
-no evaluation for carciogeicity, mutageicity or fertility impairment;
-no animal reproduction studies;
-unknown if vaccine can cause fetal harm when injected into a pregnant woman or can affect reproduction capacity;
-not recommended for pregnant women;
-unknown whether vaccine is excreted in breast milk;
-not recommended for nursing mothers;
-safety and effectiveness not established for children below 6 weeks or over 10 years;
-no immune response studies on premature infants;
-not recommended for adults;
Adverse Reactions: apnea, appetite-decrease, breath-shortness, brocospasm, diarrhea, drowsiness, edema, face edema, fever, injection site: hives, itching, lymph system, redness, irritability, seizure, shock, sleep-restless, vomiting. More adverse reactions are listed.
My Favorite
Master Artist: Karen Parker GhostWoman Studios